2023 ISPE Annual Meeting & Expo

The 2023 ISPE Annual Meeting & Expo will usher in a revitalized focus on excellence, modernization, and harmonization in pharmaceutical science and manufacturing across the globe, offering pharma professionals the opportunity to engage in industry-critical conversations. A comprehensive education program provides attendees with technical sessions on the latest developments in supply chain, operations, facilities, equipment, information systems, product development, production systems, quality systems, regulatory guidance and cutting-edge industry innovations. This signature event draws pharmaceutical and biopharmaceutical professionals at all levels of the industry from emerging leaders to the most senior executives in drug manufacturing, supply chain, devices and equipment and services, and global regulatory agencies. The conference Partner Showcase presents a large offering of the latest technologies and services for the pharmaceutical industry.

Education Tracks and Sessions will be focused on topics critical to our industry and regulatory members.

  • Raise your level of technical knowledge through peer-reviewed non-commercial education content from recognized experts in the field
  • Expand your professional network throughout the conference in educational sessions, the exhibit hall, and numerous special events
  • Enhance your individual and company’s recognition among industry colleagues through face-to-face interaction

Call for Proposals Timeline

  • Submission Opens
  • Submission Deadline
  • Notifications Sent

Why Attend the 2023 ISPE Annual Meeting & Expo?


    Program Committee

    Lisa J. Graham, PhD, PE
    Chief Executive Officer
    Seeq Corporation
    Chair
    Joydeep Ganguly
    Senior Vice President, Corporate Operations
    Gilead Sciences Inc
    Executive Chair
    Robert E. Perks, MSc, CEng
    Regional Manager
    Cognizant Life Sciences Manufacturing
    Past Chair
    David Churchward
    Global Head Sterility Assurance, Cell and Gene Technologies
    Lonza Biologics
    Board Liaison
    Sarah C. Pope Miksinski, PhD
    Executive Director in CMC Regulatory Affairs
    AstraZeneca
    Regulatory Advisor
    Ciby Abraham, PhD
    Senior Director and Group Manager, Project and Product Leadership
    AstraZeneca
    Dante Amatangelo
    Executive Consultant
    PQE Group
    Emerging Leader
    Chelsea Coffey
    Clinical Drug Supply Change Control
    Biogen
    Emerging Leader
    Amanat Kaur
    Bioprocess Consultant
    Hyde Engineering & Consulting
    Emerging Leader
    Niranjan S. Kulkarni, PhD
    Senior Director, Consulting Services | Associate
    CRB
    Connie Langer
    Director, CMC - Global Regulatory
    Pfizer
    Shanshan Liu
    Director
    No Deviation Pte Ltd
    Ryan Paul Mazur
    Process Engineer
    Genesis
    Emerging Leader
    Line Lundsberg-Nielsen, PhD
    Managing Consultant, Compliance Consulting
    NNE
    Mark O'Connor
    Technical Lead and Production Start-up Manager
    AstraZeneca
    Emerging Leader
    Charlie C. Wakeham
    APAC GxP Compliance Manager
    Waters Corporation
    Aaron Weinstein
    Senior Director, Validation Services
    IPS

    Receive Notifications

    Stay up-to-date on registration, education opportunities, speakers, hotel discounts, exhibitor information, and more by signing up to receive notifications for the 2023 ISPE Annual Meeting & Expo.

    Name
    Company Type